PROMISE Technology’s Leading RAID Storage Solutions for Rich Media Now Available in Middle East & South Korea

New distribution partnerships expand access to the brand’s top PromiseRAID technology for post-production, broadcast, sports, and education applications DUBAI, UAE, SEOUL, South Korea and HSINCHU, March 12, 2024 /PRNewswire/ — PROMISE Technology, a leader in RAID storage and streaming data solutions, is announcing its full suite of Rich Media solutions are now available across the […]

Rently Expands As The First Deposit-Free Multi-Industry Rental Platform in Singapore in Collaboration with The Working Capitol and Smart City Kitchens

Introducing a comprehensive one stop platform in making renting accessible and affordable in the property, co-working and hospitality marketplace SINGAPORE, March 12, 2024 /PRNewswire/ — Rently, a fintech startup in the property space with a mission to provide accessibility, transparency and efficiency in the rental-market ecosystem through deposit-free subscriptions and end-to-end support, is partnering with co-working […]

Acclime announces expansion into UAE with acquisition and rebranding of MeiPro

HONG KONG, March 12, 2024 /PRNewswire/ — Acclime, Asia’s leading professional corporate and advisory services specialist, is pleased to announce its formal entry into the United Arab Emirates (UAE) market. This expansion allows Acclime to service multinational and regional companies looking to establish and manage their operations within the UAE. Acclime will offer a comprehensive […]

Casio to Release Uterocervical Observation Camera in the United States, Australia and New Zealand

FDA Registration Completed in the United States and TGA Approval Obtained in Australia TOKYO, March 12, 2024 /PRNewswire/ — Casio Computer Co., Ltd. announced today that the DZ-C100 COLPOCAMERA, which is designed for uterocervical observation and photography in gynecological settings, and the CST-100M camera stand are released in the US, Australia and New Zealand today. The […]

Everest Medicines’ Partner Calliditas Therapeutics Announces U.S. FDA Grants an Additional Seven-Year Orphan Drug Exclusivity Period for Nefecon®

SHANGHAI, March 12, 2024 /PRNewswire/ — Everest Medicines (HKEX 1952.HK, “Everest”, or the “Company”)’s licensing partner Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) (“Calliditas”) announced that the U.S. FDA has granted an orphan drug exclusivity period of seven years for Nefecon®, expiring in December 2030 based on Calliditas obtaining full approval with a new […]

SK Biopharmaceuticals Announces 100,000 Patients Globally Have Been Treated with Cenobamate Through Sales of XCOPRI® and ONTOZRY® in the U.S., Europe, Israel, and Canada

Milestone Coincides with SK Biopharmaceuticals’ Global Plan Expanding Cenobamate Access to More Than 100 Markets Worldwide SEOUL, South Korea and ROME, March 12, 2024 /PRNewswire/ — SK Biopharmaceuticals Co., Ltd., a global biotech focused on developing treatments for central nervous system (CNS) disorders and oncology, and the first and only Korean company to independently develop and commercialize […]

Innovent to Present Preclinical Data of Multiple Novel Molecules at the 2024 AACR Annual Meeting

ROCKVILLE, Md. and SUZHOU, China, March 12, 2024 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology and other major diseases, announces that preclinical data on multiple novel bispecific antibodies as well as antibody-drug-conjugates (ADCs) […]

xcube launches CVPE: A New Asset Class for Family Offices and UHNWIs

SINGAPORE, March 12, 2024 /PRNewswire/ — Singapore-based corporate venture studio xcube has announced the launch of Corporate Venture Portfolio Equities (CVPE), a new asset class aiming to disrupt traditional investment models. Unlike conventional methods that focus on individual startups, CVPE introduces a holistic approach by investing in an interconnected ecosystem of tech startups, thereby offering […]

China-Malaysia Diplomatic Relations Commemorate 50th Anniversary with Successful Conclusion of the 2nd China-Malaysia Science and Technology Innovation Summit

KUALA LUMPUR, Malaysia, March 12, 2024 /PRNewswire/ — The 2nd China-Malaysia Science and Technology Innovation Summit, themed “Fostering Collaborative Innovation, Building the Future Together,” took place on March 6th to 7th, 2024, at MRANTI PARK in Kuala Lumpur, Malaysia. This significant event commemorated the 50th anniversary of diplomatic relations between China and Malaysia, aiming to […]

DPC Dash – Domino’s Pizza China (1405.HK) Achieved Substantial Growth with Go-Deeper and Go-Broader Expansion Strategy

HONG KONG, March 12, 2024 /PRNewswire/ — DPC Dash Ltd (“DPC Dash” or the “Company”, together with its subsidiaries, the “Group”) (1405.HK), Domino’s Pizza’s exclusive master franchisee in the China Mainland, the Hong Kong Special Administrative Region of China, and the Macau Special Administrative Region of China, announced a profit alert for the year ended […]

BRI Microfinance Outlook 2024: President Jokowi Commends BRI’s Commitment to Drive Economic Growth Through Financial Inclusion

JAKARTA, Indonesia, March 12, 2024 /PRNewswire/ — PT Bank Rakyat Indonesia (Persero) Tbk (IDX: BBRI) hosted the BRI Microfinance Outlook 2024, opening on March 7th with Indonesian President Joko Widodo underscoring the pivotal role of Micro, Small, and Medium Enterprises (MSMEs) for the nation’s economy. With around 65 million MSMEs contributing 61 percent to the country’s […]

Appointment of Dr Darren Patti to Group Chief Operating Officer

MELBOURNE, Australia, March 12, 2024 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) is pleased to announce the appointment of Dr. Darren Patti as Group Chief Operating Officer (COO), effective 11 March 2024. Dr. Patti joined Telix in March 2021 to lead the Company’s United States (U.S.) operations. Over the past three years […]

1 2,162 2,163 2,164 3,104